Juliana Dias, PhD
Head of GMP CAR T Production Centre for Cell, Gene and Tissue Therapeutics
Juliana Dias graduated from the Federal University of Rio de Janeiro with a BSc in Biophysics/Biotechnology, she then completed her PhD in Biophysics. Dr. Dias worked in clinical cell therapy in the Brazilian National Institute of Cancer for six years before joining UCL in 2017 to set up the CAR T manufacturing platform at the CCGTT. Dr. Dias currently leads the CAR T manufacturing team for the development and delivery of new products for the UCL Phase 1 clinical trials. The trial have delivered almost 100 product batches for patients enrolled in 8 different Phase 1 CAR T trials, 3 actively recruiting patients with B cell malignancies and Multiple Myeloma and with 8 new trials at different stages of development and implementation.